Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in AMICUS THERAPEUTIC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 557,170 shares of FOLD (AMICUS THERAPEUTIC), worth $8.1M as of 2026-Q1. The position was decreased (-35.0% shares). FOLD represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$8.1M
Current Shares
557,170
Total Value Change
+$2.8M
Total Shares Change
+23,091
Other major holders of FOLD: BNP PARIBAS FINANCIAL MARKETS
Decreased |
| 557,170 |
-35.0% |
| $8.1M |
| 0.0% |
| $14.34 |
0 |
| 2025-Q4 | Increased | 857,834 | +4.2% | $12.2M | 0.0% | $14.25 | 29 |
| 2025-Q3 | Decreased | 822,931 | -34.5% | $6.5M | 0.0% | $7.94 | 0 |
| 2025-Q2 | Increased | 1.3M | +17.1% | $7.2M | 0.0% | $5.93 | 32 |
| 2025-Q1 | Increased | 1.1M | +11.9% | $8.8M | 0.0% | $8.43 | 31 |
| 2024-Q4 | Increased | 958,671 | +97.0% | $9M | 0.0% | $9.41 | 44 |
| 2024-Q3 | Decreased | 486,769 | -8.9% | $5.2M | 0.0% | $10.71 | 0 |
| 2024-Q2 | Increased | 534,079 | +112.6% | $5.3M | 0.0% | $9.92 | 44 |